{
  "id": "644975e1d7294dc9",
  "title": "STAT+: FDA puts off Stoke\u2019s request for faster filing of severe epilepsy drug",
  "description": "Stoke Therapeutics and the FDA were unable to reach agreement on an expedited submission for the company\u2019s severe epilepsy treatment, the company said Sunday.",
  "content": "Stoke Therapeutics and the FDA were unable to reach agreement on an expedited submission for the company\u2019s severe epilepsy treatment, the company said Sunday.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/11/stoke-therapeutics-fda-expedited-submission-severe-epilepsy-zorevunersen-dravet/?utm_campaign=rss",
  "published_at": "2026-01-11T19:00:00+00:00",
  "fetched_at": "2026-01-12T00:24:39.879979+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: FDA puts off Stoke\u2019s request for faster filing of severe epilepsy drug",
    "description": "Stoke Therapeutics and the FDA were unable to reach agreement on an expedited submission for the company\u2019s severe epilepsy treatment, the company said Sunday.",
    "url": "https://www.statnews.com/2026/01/11/stoke-therapeutics-fda-expedited-submission-severe-epilepsy-zorevunersen-dravet/?utm_campaign=rss",
    "published": "2026-01-11T19:00:00+00:00",
    "source": "STAT"
  }
}